133 related articles for article (PubMed ID: 7786521)
1. Treatment of psoriasis with anthrones-chemical principles, biochemical aspects, and approaches to the design of novel derivatives.
Wiegrebe W; Müller K
Skin Pharmacol; 1995; 8(1-2):1-24. PubMed ID: 7786521
[TBL] [Abstract][Full Text] [Related]
2. Antipsoriatic anthrones: aspects of oxygen radical formation, challenges and prospects.
Müller K
Gen Pharmacol; 1996 Dec; 27(8):1325-35. PubMed ID: 9304402
[TBL] [Abstract][Full Text] [Related]
3. Structure specificity of the antipsoriatic anthrones.
Krebs A; Schaltegger H; Schaltegger A
Br J Dermatol; 1981 Aug; 105 Suppl 20():6-11. PubMed ID: 7284267
[TBL] [Abstract][Full Text] [Related]
4. Hydroxyl radical damage to DNA sugar and model membranes induced by anthralin (dithranol).
Müller K; Gürster D
Biochem Pharmacol; 1993 Nov; 46(10):1695-704. PubMed ID: 8250955
[TBL] [Abstract][Full Text] [Related]
5. Antipsoriatic and proinflammatory action of anthralin. Implications for the role of oxygen radicals.
Müller K
Biochem Pharmacol; 1997 May; 53(9):1215-21. PubMed ID: 9214681
[TBL] [Abstract][Full Text] [Related]
6. Current status and recent developments in anthracenone antipsoriatics.
Müller K
Curr Pharm Des; 2000 Jun; 6(9):901-18. PubMed ID: 10828315
[TBL] [Abstract][Full Text] [Related]
7. Antipsoriatic anthrones with modulated redox properties. 2. Novel derivatives of chrysarobin and isochrysarobin--antiproliferative activity and 5-lipoxygenase inhibition.
Müller K; Leukel P; Ziereis K; Gawlik I
J Med Chem; 1994 May; 37(11):1660-9. PubMed ID: 8201600
[TBL] [Abstract][Full Text] [Related]
8. [Antipsoriatic effect of dithranol (anthralin). 1].
Raab W
Hautarzt; 1975 Sep; 26(9):452-5. PubMed ID: 1184389
[TBL] [Abstract][Full Text] [Related]
9. Dithranol: a review of the mechanism of action in the treatment of psoriasis vulgaris.
Kemény L; Ruzicka T; Braun-Falco O
Skin Pharmacol; 1990; 3(1):1-20. PubMed ID: 2202336
[TBL] [Abstract][Full Text] [Related]
10. Detection and characterization of 9-anthron-10-yl radicals formed by antipsoriatic and tumor-promoting 9-anthrones in aqueous buffers.
Hayden PJ; Chignell CF
Chem Res Toxicol; 1993; 6(2):231-7. PubMed ID: 8386561
[TBL] [Abstract][Full Text] [Related]
11. Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). I. Phase I clinical trial of 10-propionyl dithranol and 10-butyryl dithranol (butantrone).
Mustakallio KK; Brandt H
Acta Derm Venereol; 1984; 64(1):63-6. PubMed ID: 6203285
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships for the formation of secondary radicals and inhibition of keratinocyte proliferation by 9-anthrones.
Hayden PJ; Free KE; Chignell CF
Mol Pharmacol; 1994 Jul; 46(1):186-98. PubMed ID: 8058052
[TBL] [Abstract][Full Text] [Related]
13. Free radicals and the treatment of psoriasis with special reference to dithranol.
Mustakallio KK; Martinmaa J; Vilvala R; Halmekoski J
Med Biol; 1984; 62(2):155-8. PubMed ID: 6471937
[No Abstract] [Full Text] [Related]
14. Antipsoriatic drug action of anthralin: oxidation reactions with peroxidizing lipids.
Ducret F; Lambelet P; Löliger J; Savoy MC
J Free Radic Biol Med; 1985; 1(4):301-6. PubMed ID: 3836247
[TBL] [Abstract][Full Text] [Related]
15. Anthralin derivatives--inhibition of 5-lipoxygenase--antipsoriatic efficacy.
Tanzer H; Braun C; Seidel M; Wiegrebe W
Arch Pharm (Weinheim); 1991 Nov; 324(11):841-6. PubMed ID: 1804060
[TBL] [Abstract][Full Text] [Related]
16. [Antipsoriatic effect of dithranol (anthralin). 2].
Raab W
Hautarzt; 1975 Sep; 26(9):456-9. PubMed ID: 1102494
[No Abstract] [Full Text] [Related]
17. Antipsoriatic anthrones with modulated redox properties. 1. Novel 10-substituted 1,8-dihydroxy-9(10H)-anthracenones as inhibitors of 5-lipoxygenase.
Müller K; Gürster D; Piwek S; Wiegrebe W
J Med Chem; 1993 Dec; 36(25):4099-107. PubMed ID: 8258834
[TBL] [Abstract][Full Text] [Related]
18. Antipsoriatic anthrones with modulated redox properties. 3. 10-thio-substituted 1,8-dihydroxy-9(10H)-anthracenones as inhibitors of keratinocyte growth, 5-lipoxygenase, and the formation of 12(S)-HETE in mouse epidermis.
Müller K; Huang HS; Wiegrebe W
J Med Chem; 1996 Aug; 39(16):3132-8. PubMed ID: 8759634
[TBL] [Abstract][Full Text] [Related]
19. An immunohistochemical assessment of the response of the psoriatic lesion to single and repeated applications of high-dose dithranol cream.
Swinkels OQ; Prins M; Gerritsen MJ; van Vlijmen-Willems IM; van der Valk PG; van de Kerkhof PC
Skin Pharmacol Appl Skin Physiol; 2002; 15(6):393-400. PubMed ID: 12476013
[TBL] [Abstract][Full Text] [Related]
20. Antipsoriatic anthrones with modulated redox properties. 5. Potent inhibition of human keratinocyte growth, induction of keratinocyte differentiation, and reduced membrane damage by novel 10-arylacetyl-1,8-dihydroxy-9(10H)-anthracenones.
Müller K; Reindl H; Breu K
J Med Chem; 2001 Mar; 44(5):814-21. PubMed ID: 11262091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
